On the cusp.
A nice short week then into May. Poised to run......
"Sofpironium bromide stands out as a novel “soft anti-cholinergic” developed by BLI, marking a significant advancement in hyperhidrosis treatment. Licensed to Fresh Tracks Therapeutics in 2012 and recently acquired by Botanix Pharmaceuticals, sofpironium bromide (SofdraTM) is on the cusp of FDA approval, anticipated in mid-2024. Already a success in Japan as ECCLOCK®, the drug is poised for further market expansion in South Korea through a partnership with Dong Wha Pharmaceutical."
BOT - Anything but charting, page-7981
-
- There are more pages in this discussion • 1,399 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 35.0¢ | $1.557M | 4.337M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 82172 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 284292 | 8 |
View Market Depth
| Last trade - 15.55pm 23/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |